Molecular Targeting of VEGF with a Suramin Fragment–DOCA Conjugate by Mimicking the Action of Low Molecular Weight Heparins
Molecular targeting of growth factors has shown great therapeutic potential in pharmaceutical research due to their roles in pathological conditions. In the present study, we developed a novel suramin fragment and deoxycholic acid conjugate (SFD) that exhibited the potential to bind to the heparin-b...
Main Authors: | Jooho Park, Tae-Bong Kang, Ji-Hong Lim, Hyung-Sik Won |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/1/46 |
Similar Items
-
Suramin, an antiparasitic drug, stimulates adipocyte differentiation and promotes adipogenesis
by: Hanxiao Li, et al.
Published: (2023-12-01) -
Suramin Targets the Conserved Ligand-Binding Pocket of Human Raf1 Kinase Inhibitory Protein
by: Chenyun Guo, et al.
Published: (2021-02-01) -
Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder
by: David Hough, et al.
Published: (2023-11-01) -
Structural Basis of Inhibition of the Pioneer Transcription Factor NF-Y by Suramin
by: Valentina Nardone, et al.
Published: (2020-10-01) -
The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo
by: Peijun Ren, et al.
Published: (2014-01-01)